Articles published by Gilead Sciences, Inc.
![](https://mms.businesswire.com/media/20230614274423/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230604005049/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20230604005036/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230604005045/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20230602005426/en/1810084/5/ARCUS_Logo_RGB_1920x1080.jpg)
![](https://mms.businesswire.com/media/20230531006043/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230525005607/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230525005009/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20230516005951/en/1795631/5/GILEAD_KITE_Logo_Stack_RGB_012622.jpg)
![](https://mms.businesswire.com/media/20230516005214/en/1793877/5/IMG_3592.jpg)
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20230508005799/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230504005222/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230501005622/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20230427005279/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20230413005889/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230413005787/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Sciences to Release First Quarter 2023 Financial Results on Thursday, April 27, 2023
April 13, 2023
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20230320005679/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230320005701/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20230320005116/en/1741656/22/Nurix-Logo.jpg)
![](https://mms.businesswire.com/media/20230222005741/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230222005588/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20230217005363/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230220005346/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230216005947/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230213005677/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Demonstrates Transformative Potential Impact Of Antiviral Innovation at CROI 2023
February 14, 2023
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20230209005227/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20230131006182/en/1702041/22/TRODELVY_Vial_Packaging_1.19.23.jpg)
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20230201006125/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20230202005366/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
Tickers
GILD
![](https://mms.businesswire.com/media/20230131006146/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
Tickers
GILD
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.